Basit Salik

Basit Salik

Auto-generated profile, based on publicly available information

Basit Salik

Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland, 4006, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Cancer Cell
Verified
Journal Article
Closed access
BSBasit Salik
Basit Salik
HYHangyu Yi
Hangyu Yi
NHNunki Hassan
Nunki Hassan
NSNancy Santiappillai
Nancy Santiappillai
BVBinje Vick
Binje Vick
JWJenny Y Wang
Jenny Y Wang

12 August 2020 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
BSBasit Salik
Basit Salik
MSMark J. Smyth
Mark J. Smyth
KNKyohei Nakamura
Kyohei Nakamura
Immune checkpoint blockade (ICB) therapies such as anti-programmed death 1 (PD-1) and anti-CTLA-4 (cytotoxic T lymphocyte-associated protein 4) have dramatically transformed treatment in solid tumor oncology. While immunotherapeutic approaches such as stem cell transplantation and anti-cancer monoclonal antibodies have made critical contributions to improve outcomes in hematological malignancies, clinical benefits of ICB are observed in only limited tumor types that are particularly characterized by a high infiltration of immune cells. Importantly, even patients that initially respond to ICB are unable to achieve long-term disease control using these therapies. Indeed, primary and acquired resistance mechanisms are differentially orchestrated in hematological malignancies depending on tumor types and/or genotypes, and thus, an in-depth understanding of the disease-specific immune microenvironments will be essential in improving efficacy. In addition to PD-1 and CTLA-4, various T cell immune checkpoint molecules have been characterized that regulate T cell responses in a non-redundant manner. Several lines of evidence suggest that these T cell checkpoint molecules might play unique roles in hematological malignancies, highlighting their potential as therapeutic targets. Targeting innate checkpoint molecules on natural killer cells and/or macrophages has also emerged as a rational approach against tumors that are resistant to T cell-mediated immunity. Given that various monoclonal antibodies against tumor surface proteins have been clinically approved in hematological malignancies, innate checkpoint blockade might play a key role to augment antibody-mediated cellular cytotoxicity and phagocytosis. In this review, we discuss recent advances and emerging roles of immune checkpoint blockade in hematological malignancies.

8 January 2019 in Leukemia
Verified
Journal Article
Closed access
PDF file
JLJennifer R. Lynch
Jennifer R. Lynch
BSBasit Salik
Basit Salik
PCPatrick Connerty
Patrick Connerty
BVBinje Vick
Binje Vick
HLHalina Leung
Halina Leung
JWJenny Y Wang
Jenny Y Wang

1 June 2020 in Cell Reports
Verified
Journal Article
Open access
EREdwige Roy
Edwige Roy
HWHo Yi Wong
Ho Yi Wong
RVRehan Villani
Rehan Villani
TRThomas Rouille
Thomas Rouille
BSBasit Salik
Basit Salik
KKKiarash Khosrotehrani
Kiarash Khosrotehrani
To better understand the influence of ultraviolet (UV) irradiation on the initial steps of skin carcinogenesis, we examine patches of labeled keratinocytes as a proxy for clones in the interfollicular epidermis (IFE) and measure their size variation upon UVB irradiation. Multicolor lineage tracing reveals that in chronically irradiated skin, patches near hair follicles (HFs) increase in size, whereas those far from follicles do not change. This is explained by proliferation of basal epidermal cells within 60 μm of HF openings. Upon interruption of UVB, patch size near HFs regresses significantly. These anatomical differences in proliferative behavior have significant consequences for the cell of origin of basal cell carcinomas (BCCs). Indeed, a UV-inducible murine BCC model shows that BCC patches are more frequent, larger, and more invasive near HFs. These findings have major implications for the prevention of field cancerization in the epidermis.

21 February 2019 in Haematologica
Verified
Journal Article
Open access
PDF file
EGEstrella Gonzales-Aloy
Estrella Gonzales-Aloy
PCPatrick Connerty
Patrick Connerty
BSBasit Salik
Basit Salik
BLBing Liu
Bing Liu
AWAndrew J. Woo
Andrew J. Woo
JWJenny Y Wang
Jenny Y Wang

30 October 2024
Verified
Thesis
Closed access
BSBasit Salik
Basit Salik
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.